{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:44:45Z","timestamp":1792565085675,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although continuous noradrenaline infusion (CNI) is standard vasopressor therapy during the initial resuscitation of patients with septic shock, hemodynamic stabilization may not be immediate. Push-dose noradrenaline (PDNA) has been proposed as a temporary measure while CNI is being established. However, its clinical use, dosing, early hemodynamic response, and short-term safety in the emergency department (ED) are not well described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To address this gap, we conducted a single-center retrospective descriptive study at a tertiary care hospital in Japan in 2019. Adults with Sepsis-3 septic shock who received PDNA in the ED and were admitted to the intensive care unit were included. We assessed the context and dosing of PDNA administration, CNI use, mean arterial pressure (MAP) within 15\u00a0min after PDNA administration, and adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 91 patients with septic shock, 50 (55%) received PDNA. PDNA was administered at CNI initiation in 25 patients, during CNI dose escalation in 6, and as rescue administration before CNI initiation in 19. The median (interquartile range [IQR]) initial PDNA dose was 20 (20\u201330) \u00b5g. During the 15-minute observation window, 32 (64%) patients received one bolus, 14 (28%) received two, 3 (6%) received three, and 1 (2%) received four. The directly observed median (IQR) MAP was 52 (44\u201361) mmHg at initial PDNA administration (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200930) and 62 (50\u201368) mmHg 1\u00a0min later (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200925). One of 36 patients evaluable for prespecified physiological adverse events experienced an adverse event; however, no serious adverse events were documented.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this single-center retrospective descriptive study, PDNA was most commonly administered at CNI initiation, and administration was followed by an early increase in median MAP. However, the noncomparative design and concurrent resuscitative interventions preclude attribution of this change solely to PDNA administration. No serious adverse events were documented; however, safety assessment was limited owing to missing data and retrospective ascertainment. These findings do not establish the effectiveness or safety of PDNA. Prospective comparative studies with standardized monitoring are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12873-026-01773-8","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:53:29Z","timestamp":1789836809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early hemodynamic changes after the use of push-dose noradrenaline in patients presenting to the emergency department with septic shock: a descriptive study"],"prefix":"10.1186","volume":"26","author":[{"given":"Atsushi","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Akita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Urakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Mae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsunori","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"1773_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jcrc.2019.11.004","volume":"55","author":"D Colon Hidalgo","year":"2020","unstructured":"Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care. 2020;55:145\u20138.","journal-title":"J Crit Care"},{"key":"1773_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajem.2023.06.039","volume":"72","author":"N Makonnen","year":"2023","unstructured":"Makonnen N, Layng T, Hartka T. Comparison of mortality in emergency department patients with immediate versus delayed hypotension. Am J Emerg Med. 2023;72:1\u20136.","journal-title":"Am J Emerg Med"},{"key":"1773_CR3","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49:e1063\u2013143.","journal-title":"Crit Care Med"},{"key":"1773_CR4","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.chest.2020.11.051","volume":"159","author":"JM Hawn","year":"2021","unstructured":"Hawn JM, Bauer SR, Yerke J, Li M, Wang X, Reddy AJ, et al. Effect of phenylephrine push before continuous infusion norepinephrine in patients with septic shock. Chest. 2021;159:1875\u201383.","journal-title":"Chest"},{"key":"1773_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13054-026-05920-2","volume":"30","author":"M Nishikimi","year":"2026","unstructured":"Nishikimi M, Ohshimo S, Nobayashi K, Kinoshita T, Shime N. Association between initial norepinephrine dose and minute by minute mean arterial pressure. Crit Care. 2026;30:137.","journal-title":"Crit Care"},{"key":"1773_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jemermed.2025.04.021","volume":"79","author":"B Sucena Rodrigues","year":"2025","unstructured":"Sucena Rodrigues B, Caldeira D, Dantas J, Faria R. Push-dose pressors outside the operating room: systematic review and meta-analysis of observational studies. J Emerg Med. 2025;79:260\u201379.","journal-title":"J Emerg Med"},{"key":"1773_CR7","first-page":"708","volume":"25","author":"M Berkenbush","year":"2024","unstructured":"Berkenbush M, Singh L, Sessa K, Saadi R. Scoping review: Is push-dose norepinephrine a better choice? West J Emerg Med. 2024;25:708\u201314.","journal-title":"West J Emerg Med"},{"key":"1773_CR8","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology statement: Guidelines for reporting observational studies. PLoS Med. 2007;4:e296.","journal-title":"PLoS Med"},{"key":"1773_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","volume":"52","author":"PM Wieruszewski","year":"2024","unstructured":"Wieruszewski PM, Leone M, Kaas-Hansen BS, Dugar S, Legrand M, McKenzie CA, et al. Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force. Crit Care Med. 2024;52:521\u201330.","journal-title":"Crit Care Med"},{"key":"1773_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13:818\u201329.","journal-title":"Crit Care Med"},{"key":"1773_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/HJH.0b013e32803fb621","volume":"25","author":"WJ Bos","year":"2007","unstructured":"Bos WJ, Verrij E, Vincent HH, Westerhof BE, Parati G, van Montfrans GA. How to assess mean blood pressure properly at the brachial artery level. J Hypertens. 2007;25:751\u20135.","journal-title":"J Hypertens"},{"key":"1773_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ajem.2018.12.001","volume":"37","author":"A Rotando","year":"2019","unstructured":"Rotando A, Picard L, Delibert S, Chase K, Jones CMC, Acquisto NM. Push dose pressors: Experience in critically ill patients outside of the operating room. Am J Emerg Med. 2019;37:494\u20138.","journal-title":"Am J Emerg Med"},{"key":"1773_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s13181-019-00716-z","volume":"15","author":"JB Cole","year":"2019","unstructured":"Cole JB, Knack SK, Karl ER, Horton GB, Satpathy R, Driver BE. Human errors and adverse hemodynamic events related to push dose pressors in the emergency department. J Med Toxicol. 2019;15:276\u201386.","journal-title":"J Med Toxicol"},{"key":"1773_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.12793\/tcp.2018.26.4.150","volume":"26","author":"N Holford","year":"2018","unstructured":"Holford N. Pharmacodynamic principles and target concentration intervention. Transl Clin Pharmacol. 2018;26:150\u20134.","journal-title":"Transl Clin Pharmacol"},{"key":"1773_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajem.2022.08.055","volume":"61","author":"S Singer","year":"2022","unstructured":"Singer S, Pope H, Fuller BM, Gibson G. The safety and efficacy of push dose vasopressors in critically ill adults. Am J Emerg Med. 2022;61:137\u201342.","journal-title":"Am J Emerg Med"}],"container-title":["BMC Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12873-026-01773-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12873-026-01773-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12873-026-01773-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:03:12Z","timestamp":1792562592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12873-026-01773-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1773"],"URL":"https:\/\/doi.org\/10.1186\/s12873-026-01773-8","relation":{},"ISSN":["1471-227X"],"issn-type":[{"value":"1471-227X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee of Kurashiki Central Hospital approved the study (Reference No. 3699) and waived the requirement for informed consent owing to the retrospective design and use of pseudonymized data. The study was conducted in accordance with the Declaration of Helsinki and relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"274"}}